Related references
Note: Only part of the references are listed.TRPC1 inhibits the proliferation and migration of estrogen receptor-positive Breast cancer and gives a better prognosis by inhibiting the PI3K/AKT pathway
Li-Ying Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Metastatic Melanoma Patient-Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition
Rebecca L. Shattuck-Brandt et al.
CLINICAL CANCER RESEARCH (2020)
p53-Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT
Yang Yang-Hartwich et al.
MOLECULAR CANCER RESEARCH (2019)
CADM1 is a TWIST1-regulated suppressor of invasion and survival
Edward J. Hartsough et al.
CELL DEATH & DISEASE (2019)
New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer
Noura Khaled et al.
CANCERS (2019)
Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients
Areti Strati et al.
CELLS (2019)
Up-regulation of PCOLCE by TWIST1 promotes metastasis in Osteosarcoma
Shang Wang et al.
THERANOSTICS (2019)
Epithelial-to-mesenchymal transition of A549 lung cancer cells exposed to electronic cigarettes
Atena Zahedi et al.
LUNG CANCER (2018)
Curcumin induces apoptosis and cell cycle arrest via the activation of reactive oxygen species-independent mitochondrial apoptotic pathway in Smad4 and p53 mutated colon adenocarcinoma HT29 cells
Ayushi Agarwal et al.
NUTRITION RESEARCH (2018)
miR4673 improves fitness profile of neoplastic cells by induction of autophagy
Kagan Dokumcu et al.
CELL DEATH & DISEASE (2018)
Expression Clinical Significance of Claudin-7, PDL-1, PTEN, c-Kit, c-Met, c-Myc, ALK, CK5/6, CK17, p53, EGFR, Ki67, p63 in Triple-negative Single Centre Prospective Observational Study
Chloe Constantinou et al.
IN VIVO (2018)
Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression
Y. Xu et al.
ONCOGENE (2017)
VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients
Laura Schirosi et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer
Pingting Zhou et al.
MOLECULAR CANCER (2017)
The effect of immunohistochemically detected p53 accumulation in prognosis of breast cancer; A retrospective survey of outcome
Sanambar Sadighi et al.
PLOS ONE (2017)
Breast Cancer Molecular Stratification From Intrinsic Subtypes to Integrative Clusters
Hege G. Russnes et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Reactivation of p53 by MDM2 Inhibitor MI-77301 for the Treatment of Endocrine-Resistant Breast Cancer
Jianfeng Lu et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation
Yong-Qu Zhang et al.
PLOS ONE (2015)
Expression of mutant p53 in oral squamous cell carcinoma is correlated with the effectiveness of intra-arterial chemotherapy
Yadong Li et al.
Oncology Letters (2015)
Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways
Li Yang et al.
ONCOTARGET (2015)
Targeting Oncogenic Mutant p53 for Cancer Therapy
Alejandro Parrales et al.
FRONTIERS IN ONCOLOGY (2015)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Association between common risk factors and molecular subtypes in breast cancer patients
Fatma P. Turkoz et al.
BREAST (2013)
Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients
Johanna G. H. van Nes et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
A Twist box Code of p53 Inactivation: Twist box:p53 Interaction Promotes p53 Degradation
Sara Piccinin et al.
CANCER CELL (2012)
Mutant p53R175H upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells
I. Kogan-Sakin et al.
CELL DEATH AND DIFFERENTIATION (2011)
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition
Nam Hee Kim et al.
JOURNAL OF CELL BIOLOGY (2011)
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs
Chun-Ju Chang et al.
NATURE CELL BIOLOGY (2011)
Triple-negative breast cancer: Present challenges and new perspectives
Franca Podo et al.
MOLECULAR ONCOLOGY (2010)
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes (vol 107, pg 15449, 2010)
Joseph H. Taube et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells
Qing-Quan Li et al.
CLINICAL CANCER RESEARCH (2009)
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence
Stephane Ansieau et al.
CANCER CELL (2008)
Twist and p53 reciprocally regulate target genes via direct interaction
M. Shiota et al.
ONCOGENE (2008)
Control of apoptosis by p53
JS Fridman et al.
ONCOGENE (2003)
Share Paper
